Azurity Pharmaceuticals
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.xatmep.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Azurity Pharmaceuticals
Azurity Solutions specializes in pediatric treatments, particularly focusing on XATMEP®, a folate analog metabolic inhibitor. This oral solution is indicated for managing acute lymphoblastic leukemia (ALL) and polyarticular juvenile idiopathic arthritis (pJIA) in pediatric patients, designed to simplify medication routines for children. The product is characterized by its ready-to-use liquid form, sweet taste, and easy handling without the need for refrigeration. Azurity aims to make access to their medications easier for patients and caregivers, providing support to navigate coverage and prescription needs.Explore more
Popular SearchesAzurity Pharmaceuticals IncEpanedKaterziaXatmepSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Azurity Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Azurity Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Azurity Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Azurity Pharmaceuticals
Website visits: Recent activity has been detected on your website
Check out if Azurity Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Azurity Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Azurity Pharmaceuticals has new funding data
Earning: See what the market has to say on Azurity Pharmaceuticals recently announced quarterly report
Click to see if Azurity Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Azurity Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Azurity Pharmaceuticals
Compare insights from companies similar to Azurity Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Azurity Pharmaceuticals
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Azurity Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Azurity Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Azurity Pharmaceuticals.
Azurity Pharmaceuticals Tech Stack
A closer look at the technologies used by Azurity Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Azurity Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Azurity Solutions specializes in pediatric treatments, particularly focusing on XATMEP®, a folate analog metabolic inhibitor. This oral solution is indicated for managing acute lymphoblastic leukemia (ALL) and polyarticular juvenile idiopathic arthritis (pJIA) in pediatric patients, designed to simplify medication routines for children. The product... Read More
